🟢 Taysha Gene Therapies is trading 12.54% up in pre-market; catalyst remains unclear

Taysha Gene Therapies is trading at $4.94, up +12.54% in pre-market versus the October 6 close of $4.39.

• No October 7 company-specific announcement explaining the move was found.
• The latest release on its investor-relations page is dated September 4; October presentations were announced October 1, not overnight.
• Broader markets are mixed to lower pre-market, and available evidence does not establish a market-wide explanation; the cause remains uncertain.